Etozolin

This classification denotes a loop diuretic and antihypertensive agent with the molecular formula C13H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UEO8UW9V1Z, chemically known as 3-methyl-4-oxo-5-piperidino-.delta.(sup2,a)-thiazolidineacetic acid ethyl ester but generally known as etozolin, which bears US NIH Compound Identifier 5384145. European Medicines Agency schedules Etozolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07344MIG. The term ETOZOLIN is an International Non-Proprietary Name. World Health Organization schedules etozolin in its Anatomical Therapeutic Chemical (ATC) Classification. ETOZOLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etozolin under HS 29341000 and SITC 51579. As of Q4 2014, ETOZOLIN remains the US FDA Preferred Term for this commodity. Etozolin bears US NLM identifiers UMLS ID C0059877 and NCI Concept Code C65600. SMILES: S1C(N2CCCCC2)C(=O)N(C\1=C/C(=O)OCC)C.